 |
|
Cost-effectiveness of Systematic Depression Treatment Among People With Diabetes Mellitus
Gregory E. Simon, MD, MPH;
Wayne J. Katon, MD;
Elizabeth H. B. Lin, MD, MPH;
Carolyn Rutter, PhD;
Willard G. Manning, PhD;
Michael Von Korff, ScD;
Paul Ciechanowski, MD;
Evette J. Ludman, PhD;
Bessie A. Young, MD, MPH
Arch Gen Psychiatry. 2007;64(1):65-72.
Context Depression co-occurring with diabetes mellitus is associated with higher health services costs, suggesting that more effective depression treatment might reduce use of other medical services.
Objective To evaluate the incremental cost and cost-effectiveness of a systematic depression treatment program among outpatients with diabetes.
Design Randomized controlled trial comparing systematic depression treatment program with care as usual.
Setting Primary care clinics of group-model prepaid health plan.
Patients A 2-stage screening process identified 329 adults with diabetes and current depressive disorder.
Intervention Specialized nurses delivered a 12-month, stepped-care depression treatment program beginning with either problem-solving treatment psychotherapy or a structured antidepressant pharmacotherapy program. Subsequent treatment (combining psychotherapy and medication, adjustments to medication, and specialty referral) was adjusted according to clinical response.
Main Outcome Measures Depressive symptoms were assessed by blinded telephone assessments at 3, 6, 12, and 24 months. Health service costs were assessed using health plan accounting records.
Results Over 24 months, patients assigned to the intervention accumulated a mean of 61 additional days free of depression (95% confidence interval [CI], 11 to 82 days) and had outpatient health services costs that averaged $314 less (95% CI, $1007 less to $379 more) compared with patients continuing in usual care. When an additional day free of depression is valued at $10, the net economic benefit of the intervention is $952 per patient treated (95% CI, $244 to $1660).
Conclusions For adults with diabetes, systematic depression treatment significantly increases time free of depression and appears to have significant economic benefits from the health plan perspective. Depression screening and systematic depression treatment should become routine components of diabetes care.
Author Affiliations: Center for Health Studies, Group Health Cooperative (Drs Simon, Lin, Rutter, Von Korff, and Ludman), Department of Psychiatry and Behavioral Sciences (Drs Simon, Katon, and Ciechanowski), and Division of General Internal Medicine, Department of Medicine (Dr Young), University of Washington, and Epidemiologic Research and Information Center, Veterans Affairs Puget Sound Health Care System (Dr Young), Seattle; and Harris School of Public Policy Studies, University of Chicago, Chicago, Ill (Dr Manning).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Long-Term Effects on Medical Costs of Improving Depression Outcomes in Patients With Depression and Diabetes
Katon et al.
Diabetes Care 2008;31:1155-1159.
ABSTRACT
| FULL TEXT
Organized Care for Depression Improves Outcomes and Reduces Costs
Pignone
Clin. Diabetes 2008;26:15-16.
FULL TEXT
Healthy Coping, Negative Emotions, and Diabetes Management: A Systematic Review and Appraisal
Fisher et al.
The Diabetes Educator 2007;33:1080-1103.
ABSTRACT
| FULL TEXT
Collaborative care for depression in patients with diabetes increased depression free days and had economic benefit
O'Malley
Evid. Based Med. 2007;12:86-86.
FULL TEXT
Cortisol Secretion in Patients With Type 2 Diabetes: Relationship With Chronic Complications: Response to Chiodini et al.
Castillo-Quan and Perez-Osorio
Diabetes Care 2007;30:e49-e49.
FULL TEXT
|
